Diabetic Medicine commentary addresses reading lower-dose semaglutide effectiveness

The wire

1. 01Diabetic Medicine published a commentary on September 16 titled 'When dose follows response: Interpreting lower-dose semaglutide effectiveness in clinical practice.'
2. 02Prescribers weighing whether patients can be held at lower semaglutide doses are a core audience for how such effectiveness data get interpreted.
3. 03Only the title was available to the desk; the commentary's arguments, data sources and conclusions have not been reviewed here.

From the source

When dose follows response: Interpreting lower-dose semaglutide effectiveness in clinical practice

Diabetic medicine : a journal of the British Diabetic Association · 2026 Sep 16 · Kılınç S et al.